Molecular
diagnostics primarily refers to the class of diagnostic tests that
identifies nucleic acids or proteins at the molecular level.
Molecular diagnostics has emerged as one of the fastest growing
segments in in vitro diagnostics industry. The market for molecular
diagnostics has expanded rapidly since 1990’s with the introduction
of PCR test for HIV and Chlamydia trachomatis and Neisseria gonorrhea
(CT/NG). Since then, within a span of 20 years market has shown a
significant growth. Currently, molecular diagnostics kits are being
widely adopted for testing genetic diseases, cancer, hepatitis virus
and hospital acquired infections. Likewise, molecular diagnostics
kits are also being used extensively for blood donor screening test
for hepatitis and HIV.
The
molecular diagnostic tests uses a number of technologies such as
polymerase chain reaction, hybridization (ISH AND FISH), mass
spectrometry, transcription mediated amplification (TMA), next
generation sequencing, biochips and microfluidics, others which
includes nanotechnology and proteomics. The polymerase chain reaction
dominated the molecular diagnostics market in Europe accounting for
the share of 40.1% in 2014 as the technique is cost-effective way for
copying or amplification of small segments of DNA or RNA. However,
next generation sequencing segment is expected to register the
fastest growth during the forecast period due to its high throughput,
speed, flexibility which has ability to generate hundreds of
gigabases of data in a single sequencing run.
Download
Complete PDF
Brochure:
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=9434
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=9434
The
Europe molecular diagnostics market has been segmented into five
major regions, namely, Northern Europe, Eastern Europe, Western
Europe, Southern Europe, and Rest of Europe, which are further
categorized into various countries under each region. Western Europe
dominated the Europe molecular diagnostic market in 2014 with a share
of 47.1% due to factors such as rising prevalence of infectious
disorders, and increasing number of government initiatives. In
addition, growing preference of the population to opt for affordable
molecular diagnostic tests is another factor supporting the market
growth in this region. Eastern Europe is projected to be the most
lucrative market for Europe molecular diagnostic market and is
expected to expand at the highest growth rate from 2015 to 2023.
Factors propelling the growth of the Europe molecular diagnostic
market are rising disposable income among population, and rising
health care awareness among the people pertaining to molecular
diagnostic tests.
F.
Hoffmann-La Roche Ltd. dominated the Europe molecular diagnostic
market in 2014. Major factors attributed to its dominance are broad
product portfolio and widespread market presence. Abbott Laboratories
secured the second market position offering a wide range of molecular
diagnostic tests. Other players in the Europe molecular diagnostic
market include QIAGEN N.V., Hologic, Inc., Cepheid, Inc., Siemens AG,
Alere. Inc., BioMerieux, Bio-Rad Laboratories, PerkinElmer, Inc.,
Thermo Fisher Scientific, Inc., and others.
Browse
Full Research
Report:
http://www.transparencymarketresearch.com/europe-molecular-diagnostics-market.html
http://www.transparencymarketresearch.com/europe-molecular-diagnostics-market.html
About
Us
Transparency
Market Research (TMR) is a market intelligence company, providing
global business information reports and services. Our exclusive blend
of quantitative forecasting and trends analysis provides
forward-looking insight for thousands of decision makers. We have an
experienced team of Analysts, Researchers, and Consultants, who us e
proprietary data sources and various tools and techniques to gather,
and analyze information. Our business offerings represent the latest
and the most reliable information indispensable for businesses to
sustain a competitive edge.
Each
TMR Syndicated Research report covers a different sector – such as
pharmaceuticals, chemical, energy, food & beverages,
semiconductors, med-devices, consumer goods and technology. These
reports provide in-depth analysis and deep segmentation to possible
micro levels. With wider scope and stratified research methodology,
our syndicated reports thrive to provide clients to serve their
overall research requirement.
Contact
Transparency
Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
Browse market research blog: https://tmrresearch.blogspot.com/
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
Browse market research blog: https://tmrresearch.blogspot.com/
No comments:
Post a Comment